Smart patch could shield new moms with diabetes from dangerous sugar drops
NCT ID NCT06141941
First seen Apr 21, 2026 · Last updated Jun 21, 2026 · Updated 6 times
Summary
This study looked at whether using a continuous glucose monitor (CGM) — a small sensor worn on the skin — can better detect low blood sugar (hypoglycemia) in new mothers with type 1 or type 2 diabetes after childbirth, compared to the usual finger-prick tests. Thirty-nine women in their third trimester who owned a smartphone were enrolled. The goal was to see if CGM could reduce the number of hypoglycemic episodes during their hospital stay.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGESTATIONAL DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
continuous glucose monitoring (CGM) device
What this could lead to
If successful, CGM could become a standard tool to better detect and prevent low blood sugar in new mothers with diabetes during their hospital stay.
What could go wrong
This is a small, completed study with only 39 participants, so results may not apply to all patients. The device requires a smartphone and may not work for everyone.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.